Potential benefit of olive leaf extract in cervical spondylotic myelopathy model

Sabri Ibrahim, Iqbal Fahlevi Adeputra Nasution, Mahyu Danil, Wismaji Sadewo, Tri Widyawati, Putri Chairani Eyanoer, Kiking Ritarwan, Wibi Riawan, Ridha Darmajaya

Research output: Contribution to journalArticlepeer-review

4 Citations (Scopus)


Introduction: Cervical spondylosis is the most common cause of myelopathy in the cervical due to chronic compression of the spinal cord in patients aged 55 years or older. Recent studies suggest that olive extracts suppress inflammation and reduce stress oxidative injury. The purpose of this study was to determine the potential neuroprotective effects of olive leaf extract (OLE) in an experimental cervical spondylotic myelopathy model. Methods: This study was divided into 6 groups; Control Negative (Sham-Operated) Group, Control Positive 1 & 2 (early chronic and chronic), Treatment Groups 1, 2 & 3 (prophylactic, concomitant & late). Olive leaf extract (OLE) give 350 mg/kg BW and spinal cord sample was taken at the compression level C5. Histopathological assessment and immunohistochemistry of Amyloid-β, p-Tau, TDP-43 dan CD-68 dan evaluation of functional motoric outcome was done before animals were terminated. Results: Chronic spinal cord compression increased the expression of Amyloid-β, p-Tau, TDP-43 dan CD-68. OLE 350 mg/kg BW decreased the expression of these biomarkers and increased functional motoric outcome, especially as prophylactic dan concomitant treatment. Discussion: These findings indicate that OLE may be effective in protecting cervical spondylotic myelopathy.

Original languageEnglish
Article number103040
JournalAnnals of Medicine and Surgery
Publication statusPublished - Jan 2022


  • Cervical spondylotic myelopathy
  • Chronic spinal cord injury
  • Neuroprotective
  • Olive leaf extract


Dive into the research topics of 'Potential benefit of olive leaf extract in cervical spondylotic myelopathy model'. Together they form a unique fingerprint.

Cite this